- Pagina principale
- Analisi delle app
- Anticoagulation Manager
- Anticoagulation Manager Vs. AnticoagEvaluator
Anticoagulation Manager vs. AnticoagEvaluator Utilizzo e statistiche
The Anticoagulation Manager is a mobile application developed through the collaborative efforts of the CDC and the Georgia Institute of Technology. Since the determination of the correct type and dose of anticoagulant drugs can be challenging, this application is a resource for clinicians to appropriately order laboratory testing and choose anticoagulant drugs for the various indications. It gives clinicians evidence-based, accessible, and accurate information when prescribing anticoagulants to prevent and/or treat abnormal clotting states.
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
- App Store di Apple
- Gratis
- Settore Medico
Classifica degli store
- -
Anticoagulation ManagerRanking a confronto con AnticoagEvaluator
Confronta la tendenza di classifica Anticoagulation Manager nei ultimi 28 giorni rispetto a AnticoagEvaluator
Rank
Nessun dato disponibile
Classifica Anticoagulation Manager vs. AnticoagEvaluator per paese a confronto
Confronta la tendenza di classifica Anticoagulation Manager nei ultimi 28 giorni rispetto a AnticoagEvaluator
Nessun dato da visualizzare
Fai confronti con qualsiasi sito con la nostra prova gratuita


gennaio 10, 2025